We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M Turnover 23.21%
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$281M
AUM Growth
+$47.6M
Cap. Flow
+$23.4M
Cap. Flow %
8.3%
Top 10 Hldgs %
45.9%
Holding
164
New
35
Increased
26
Reduced
12
Closed
17
Avg Time Held Equity + Options
2.4 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
1.7 years
Avg Time Held Equity only
2.4 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
1.7 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VLY icon
101
Valley National Bancorp
VLY
$7B
$168K 0.06%
12,480
– –
2019 Q4
6 quarters
KHC icon
102
The Kraft Heinz Company
KHC
$28.1B
$159K 0.06%
3,901
– –
2015 Q3
23 quarters
TPST icon
103
Tempest Therapeutics
TPST
$10.5M
$155K 0.06%
1,064
+357
+50% +$80.2K
2021 Q1
1 quarter
LEGH icon
104
Legacy Housing
LEGH
$651M
$153K 0.05%
9,000
– –
2018 Q4
10 quarters
CTIC
105
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$150K 0.05%
60,000
+40,000
+200% +$95.9K
2020 Q4
2 quarters
LGV.WS
106
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$147K 0.05%
+12,780
New +$16K
2021 Q2
0 quarters
WARR.WS
107
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$144K 0.05%
+12,500
New +$7.59K
2021 Q2
0 quarters
LKFT icon
108
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.96B
$138K 0.05%
2,000
+1,000
+100% +$76.3K
2021 Q1
1 quarter
MDT icon
109
Medtronic
MDT
$121B
$130K 0.05%
1,050
– –
2014 Q3
27 quarters
CUZ icon
110
Cousins Properties
CUZ
$4.55B
$123K 0.04%
3,357
– –
2015 Q1
25 quarters
TTE icon
111
TotalEnergies
TTE
$201B
$112K 0.04%
2,460
– –
2013 Q2
32 quarters
FNB icon
112
FNB Corp
FNB
$6.13B
$110K 0.04%
8,905
– –
2014 Q3
27 quarters
XBI icon
113
State Street SPDR S&P Biotech ETF
XBI
$9.5B
$108K 0.04%
800
-3,000
-79% -$394K
2021 Q1
1 quarter
MRK icon
114
Merck
MRK
$360B
$101K 0.04%
1,300
-62
-5% -$4.61K
2021 Q1
1 quarter
TMUS icon
115
T-Mobile US
TMUS
$171B
$101K 0.04%
700
– –
2021 Q1
1 quarter
DBRG icon
116
DELISTED
DigitalBridge
DBRG
$99K 0.04%
3,117
– –
2017 Q1
17 quarters
ACQR
117
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
$93K 0.03%
+9,500
New +$93.9K
2021 Q2
0 quarters
SAIL icon
118
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$87K 0.03%
1,700
– –
2021 Q1
1 quarter
CRIS icon
119
Curis
CRIS
$987K
$81K 0.03%
25
– –
2021 Q1
1 quarter
OXY icon
120
Occidental Petroleum
OXY
$62.4B
$75K 0.03%
2,387
– –
2019 Q3
7 quarters
PRTS icon
121
CarParts.com
PRTS
$61M
$75K 0.03%
370
– –
2021 Q1
1 quarter
LLY icon
122
Eli Lilly
LLY
$1.12T
$69K 0.02%
300
– –
2013 Q3
31 quarters
EDIT icon
123
Editas Medicine
EDIT
$361M
$57K 0.02%
+1,000
New +$36.9K
2021 Q2
0 quarters
GE icon
124
GE Aerospace
GE
$326B
$47K 0.02%
698
– –
2013 Q2
32 quarters
CFFN icon
125
Capitol Federal Financial
CFFN
$1.01B
$45K 0.02%
3,800
-2,000
-34% -$25.7K
2013 Q2
32 quarters

Similar funds

David M. Knott's Q2 2021 Portfolio in Review

As of Q2 2021, David M. Knott held 164 positions worth $281M, up 20% from $234M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

David M. Knott deployed $23.4M of net new capital in Q2 2021, opening 35 new positions and adding to 26 existing holdings. Its largest new stake was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 23% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.37M trimmed.

  • David M. Knott's largest Q2 2021 buy was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.
  • David M. Knott added most to Calumet Specialty Products in Q2 2021, an estimated $1.9M increase.
  • David M. Knott's biggest Q2 2021 reduction was Gilead Sciences, cutting an estimated $2.37M.
  • David M. Knott fully exited African Gold Acquisition Corp Units in Q2 2021, selling an estimated $6.11M.
  • David M. Knott's ten largest holdings make up 46% of its $281M portfolio in Q2 2021.
  • David M. Knott opened 35 new positions and closed 17 in Q2 2021.
  • David M. Knott's portfolio value rose 20% quarter-over-quarter to $281M.

Based on David M. Knott's 13F filing for Q2 2021, filed 13 Aug 2021.